Middletown, DE -- (SBWIRE) -- 10/03/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Peregrine Pharmaceuticals (NASDAQ:PPHM), Atmel Corporation (NASDAQ:ATML), Activision Blizzard, Inc.(NASDAQ:ATVI), Keryx Biopharmaceuticals(NASDAQ:KERX)
Peregrine Pharmaceuticals (NASDAQ:PPHM) opened the session at $1.43, remained amid the day range of $1.41 - $1.54, and closed the session at $1.48. The stock showed a positive performance of +5.71% in previous trading session. The stock gained a volume of 4.98 million shares and the average volume of the stock remained 897,975.00 shares. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. It has license, research, and development agreements with the University of Texas Southwestern Medical Center; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; Lonza Biologics; Affitech A/S; UTSWMC; and Merck KGaA.
Why Should Investors Buy PPHM After The Recent Gain? Just Go Here and Find Out
Atmel Corporation (NASDAQ:ATML) traded with volume of 4.85 million shares in the prior session and the average volume of the stock remained 3.88 million shares. The 52 week range of the stock remained $4.37 - $8.40. The stock showed a positive movement of +0.07% and closed its session at $7.43. The market capitalization of the stock remained 3.18 billion. Atmel Corporation designs, develops, manufactures, and sells semiconductor integrated circuit (IC) products. The company?s Microcontrollers segment provides various proprietary and non-proprietary solutions, such as Atmel?s capacitive touch products, including maXTouch and QTouch, AVR 8-bit and 32-bit products, ARM-based products, Atmel?s 8051 8-bit products, as well as XSense products.
Is ATML a Solid Investment at These Levels? Read This Report For Details
Activision Blizzard, Inc.(NASDAQ:ATVI) exchanged 4.78 million shares and the average volume remained 5.47 million shares. The stock dropped -0.68% and closed the session at $16.78. The beta of the stock remained 0.67 and the EPS of the stock remained 1.19. The shares outstanding of the stock remained 1.12 billion. Activision Blizzard, Inc. publishes online, personal computer (PC), console, handheld, and mobile interactive entertainment products worldwide. It operates in three segments: Activision, Blizzard, and Distribution. The Activision segment develops and publishes interactive software products and content.
Has ATVI Found The Bottom And Ready To Gain Momentum? Find Out Here
Keryx Biopharmaceuticals (NASDAQ:KERX) gained volume of 4.66 million shares, while the average volume remained 1.72 million shares. The stock advanced +0.29% and finished the session Wednesday at $10.42. The EPS of the stock remained -0.33. The one month of the stock was +22.16% and three month trend remained positive +32.40%. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes.
For How Long KERX’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)